Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
What if you miss a dose
Retatrutide is an investigational GIP, GLP-1, and glucagon triple receptor agonist not yet approved by the MHRA or EMA
ONGOING FUTURE STUDIES OF GLP-1R AGONISTS CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported
If you are looking for weight loss treatment, you should only ever buy from a trusted and licensed service and choose treatments that are MHRA-approved and prescribed by a qualified medical professional
People who are underweight or malnourished
J.et al (2013)
US$ 26.63
US$ 29.90
US$ 25.47
